Clinical Trials
4 trialsNCT00867568 2024-08-06
TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma
Milton S. Hershey Medical Center
Phase 1 Completed
NCT01332630 2018-09-20
TPI 287 in Breast Cancer Metastatic to the Brain
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00113724 2009-06-04
Study of TPI 287 in Patients With Advanced Malignancies
Cortice Biosciences, Inc.
Phase 1 Completed
NCT00256191 2007-10-15
Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies
Cortice Biosciences, Inc.
Phase 1 Completed